![Fibrosis: a key feature of Fabry disease with potential therapeutic implications | Orphanet Journal of Rare Diseases | Full Text Fibrosis: a key feature of Fabry disease with potential therapeutic implications | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1750-1172-8-116/MediaObjects/13023_2013_Article_613_Fig2_HTML.jpg)
Fibrosis: a key feature of Fabry disease with potential therapeutic implications | Orphanet Journal of Rare Diseases | Full Text
![Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy | Journal of Medical Genetics Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/54/11/771/F3.large.jpg)
Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy | Journal of Medical Genetics
![IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report - Wen Hao, Lina Ao, Chenli Zhang, Lei Zhu, Deqiong Xie, 2020 IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report - Wen Hao, Lina Ao, Chenli Zhang, Lei Zhu, Deqiong Xie, 2020](https://journals.sagepub.com/cms/10.1177/0300060519891290/asset/images/large/10.1177_0300060519891290-fig1.jpeg)
IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report - Wen Hao, Lina Ao, Chenli Zhang, Lei Zhu, Deqiong Xie, 2020
![Pathologic substrate of gastropathy in Anderson-Fabry disease | Orphanet Journal of Rare Diseases | Full Text Pathologic substrate of gastropathy in Anderson-Fabry disease | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-020-01436-2/MediaObjects/13023_2020_1436_Fig1_HTML.png)
Pathologic substrate of gastropathy in Anderson-Fabry disease | Orphanet Journal of Rare Diseases | Full Text
![Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence - Kidney International Reports Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence - Kidney International Reports](https://www.kireports.org/cms/asset/ab8dbcf2-d389-4132-b771-719f75df6e5e/gr1.jpg)
Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence - Kidney International Reports
![Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy: Molecular Therapy Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy: Molecular Therapy](https://www.cell.com/cms/attachment/cf38ff06-bb5c-482c-8061-6eed1fb117ec/gr3_lrg.jpg)
Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy: Molecular Therapy
GLA-mutant kidney organoids recapitulated human renal Fabry disease. a... | Download Scientific Diagram
![Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy - ScienceDirect Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527317329261-gr1.jpg)
Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy - ScienceDirect
![Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease: Molecular Therapy Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease: Molecular Therapy](https://www.cell.com/cms/attachment/019f7430-fffd-438f-90d8-408d5fc11e5b/fx1_lrg.jpg)
Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease: Molecular Therapy
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases | PLOS ONE
![Improvement in Cardiac Function in the Cardiac Variant of Fabry's Disease with Galactose-Infusion Therapy | NEJM Improvement in Cardiac Function in the Cardiac Variant of Fabry's Disease with Galactose-Infusion Therapy | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2001/nejm_2001.345.issue-1/nejm200107053450104/production/images/img_medium/nejm200107053450104_f1.jpeg)